-
-
Featured Care Areas

This panel information applies to Integrated Shield Plans only. Please check with your insurer for their most up-to-date list of panel doctors.
^Specialists may qualify for Extended Panel (EP) benefits depending on your policy and riders.
Dr Michelle Kam is a pulmonologist at Mount Elizabeth Hospitals, Gleneagles Hospital, and Parkway East Hospital in Singapore.
She specialises in respiratory medicine and treats conditions including asthma, chronic obstructive pulmonary disease, bronchiectasis and chronic cough.
She also performs procedures including bronchoscopy and endobronchial ultrasound. Her clinical interests are in interstitial lung disease and rare lung diseases.
She completed a subspecialty fellowship in interstitial lung disease and orphan lung diseases at National Jewish Health, a leading respiratory centre in the USA, with one of the largest and most established interstitial lung disease programs in the nation.
During her fellowship, she also received training in sarcoidosis and granulomatous lung disease, orphan and cystic lung disease (e.g. lymphangioleiomyomatosis, Birt-Hogg Dube Syndrome, pulmonary Langerhans cell histiocytosis), childhood interstitial lung disease and pulmonary genetics.
Prior to entering private practice, Dr Kam served as the associate director of a hereditary haemorrhagic telangiectasia treatment centre and established a cystic lung disease clinic. She was involved in multidisciplinary care for immunotherapy-related toxicities and participated in combined respiratory and rheumatology clinics.
She currently serves as the deputy head of the Interstitial Lung Disease Assembly at the Asian Pacific Society of Respirology.
Dr Kam has received various awards, including the Class of 1975 Book Prize, SingHealth Best House Officer Award, and Service with a Heart Award. More recently, she received the inaugural Singapore Thoracic Society Young Investigator’s Award in 2022, as well as the 2025 ATS-APSR Travel Award. She is well-published in international peer-reviewed journals and has been an invited speaker and faculty member at local, regional and international conferences.
Kam, M. L. W., Chong, S. T., Chan, S. H., Swigris, J. J., Chew, E. L., Tan, Y. H., Ngeow, J. Y. Y., & Low, S. Y. (n.d.). First ever characterisation of the effects of short telomeres in a Singapore interstitial lung disease cohort.
Kam, M. L. W., Li, H. H., Tan, Y. H., & Low, S. Y. (2019). Validation of the ILD-GAP model and a local nomogram in a Singaporean cohort. Respiration, 98(5), 383–390
Kam, M. L. W., Tiew, P. Y., Chai, H. Z., & Low, S. Y. (2022). Cluster phenotypes in a non-idiopathic pulmonary fibrosis fibrotic interstitial lung diseases cohort in Singapore. Journal of Thoracic Disease, 14(7), 2481–2492.
Kam, M. L. W., Tjong, E. L., Chaudhary, S., Koelsch, T. L., Pryor, J. B., Koslow, M., Mohning, M. P., Solomon, J. J., Huie, T. J., Swigris, J. J., & Fernández Pérez, E. R. (2025). Development and validation of a clinical, CT, genomic classifier and BAL scoring system for diagnosing IPF. European Respiratory Journal.